KMB

AI Memo

Kimberly-Clark

As of 2026-10-02/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-02 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

China diaper sales and revised 2026 outlook • 2026-12-31

Base target: $94 / p=50% prob

Biggest risk

Q2 organic sales were slightly negative, while China disruption, price investments and business exits weighed on performance. The pending acquisition adds closing, financing and integration risk. The COO's planned departure adds execution uncertainty. [#SEC-8K-2026-08-04] SEC earnings exhibit [#8-K-2026-10-01] SEC filing

Invalidation

Break below $75 or thesis failure.

What would change my mind?

Q2 adjusted gross margin rose 190 basis points year over year and adjusted continuing-operations EPS rose 10.4%; sustained productivity and a recovery in China could improve earnings quality. These are company-reported, partly adjusted measures. [#SEC-8K-2026-08-04] SEC earnings exhibit

Research note

Recommendation

—

Confidence

medium

As of

2026-10-02

Base target

$94

p=50%

Bull target

$112

p=25%

Bear target

$75

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

President and COO departure
Pending Kenvue acquisition
Q2 adjusted gross margin rose 190 basis points year over year and adjusted continuing-operations EPS rose 10.4%; sustained productivity and a recovery in China could improve earnings quality.

BearKey bullets

China diaper-sales disruption may persist beyond management's near-term expectations.
[#SEC-8K-2026-08-04]
Reported margin improvement included one-time tariff refunds; pricing investments and supply-chain spending may limit repeatability.

WatchKey bullets

China diaper sales and revised 2026 outlook

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $94 (p=50%)

Target spread vs base: +19% / -20%

Scenario probabilities

Bull Target: $112 (p=25%)Base Target: $94 (p=50%)Bear Target: $75 (p=25%)

Commentary

Recent supplied headlines focus on Torres's departure, which the SEC filing confirms. The packet does not establish a post-announcement price reaction, current analyst revisions, options positioning or sufficient social coverage; the zero-valued sentiment fields denote unavailable measurements, not neutral observations. The deterministic directional prior is neutral despite strong primary-source coverage.

As of 2026-10-02 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

President and COO departure
Pending Kenvue acquisition

Scenarios

Bull Target (Scenario probability)

$112 / p=25% prob

Base Target (Scenario probability)

$94 / p=50% prob

Bear Target (Scenario probability)

$75 / p=25% prob

Analysis 2026-10-02 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-12-31
China diaper sales and revised 2026 outlook
The August earnings release attributed a significant China diaper-sales disruption to false quality allegations and expected further near-term effects. It revised expected 2026 organic growth to approximately 100 basis points below weighted category growth. Evidence that sales stabilize—or that the disruption persists—would test that outlook. [#SEC-8K-2026-08-04] SEC earnings exhibit
Prob 65.00% • Move 4.00% • Priced-in 45.00%

Short-term Catalysts

Next few weeks

President and COO departure
2026-11-02
Russell Torres is scheduled to depart on November 2. The filing does not name a successor; leadership continuity during the company's transformation is the near-term issue to monitor. [#8-K-2026-10-01] SEC filing
Prob 100% • Move -2% • Priced-in 60%

Long-term Catalysts

Months to a year

Pending Kenvue acquisition
2026-12-31
Management said in August that the pending acquisition remained on track to close by year-end 2026. Completion, financing terms and eventual integration benefits remain unproven; year-end is management's stated target, not a confirmed closing date. [#SEC-8K-2026-08-04] SEC earnings exhibit
Prob 65% • Move 5% • Priced-in 55%

Risks

China diaper-sales disruption may persist beyond management's near-term expectations. [#SEC-8K-2026-08-04]
Reported margin improvement included one-time tariff refunds; pricing investments and supply-chain spending may limit repeatability. [#SEC-8K-2026-08-04]
The Kenvue acquisition was pending as of the August release; closing, financing and integration benefits are uncertain. [#SEC-8K-2026-08-04]
The president and COO is scheduled to depart November 2, with no successor named in the October 1 filing. [#8-K-2026-10-01]

Peers

Symbol	Summary
CHD	Secondary household and personal-care comparator for branded-product pricing and margins, but less direct than P&G or Essity for diapers and tissue.
CLX	Secondary branded household-products comparator for pricing and productivity; its category mix limits direct comparisons with KMB's baby care and tissue businesses.
PG	Direct operating comparator across diapers, feminine care and tissue: P&G lists Pampers, Always, Charmin and Bounty. Its broader portfolio and larger scale limit company-wide multiple comparisons. P&G brands

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-02

Loading AI feed…

Symbol

Summary

CHD

Secondary household and personal-care comparator for branded-product pricing and margins, but less direct than P&G or Essity for diapers and tissue.

CLX

Secondary branded household-products comparator for pricing and productivity; its category mix limits direct comparisons with KMB's baby care and tissue businesses.

Direct operating comparator across diapers, feminine care and tissue: P&G lists Pampers, Always, Charmin and Bounty. Its broader portfolio and larger scale limit company-wide multiple comparisons. P&G brands